ResearcherUniversity of TsukubaActive in the last 2 years
Takahito Nakajima
Matched on ORCID iD 0000-0001-6704-2297; OpenAlex author ID A5041451157. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2022: 1 paper · 2023: 2 papers · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- Stromal FAP-targeted 18F-FAPI-74 PET/CT in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2026.07.004↗
- Lectin-based phototherapy targeting cell surface glycans for pancreatic cancer. Co-author DOI 10.1002/ijc.34362↗
- Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally advanced pancreatic cancer: a phase I/II… Co-author DOI 10.1186/s12885-023-11110-y↗
- Robust Validation and Comprehensive Analysis of a Novel Signature Derived from Crucial Metabolic Pathways of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cancers14071825↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tatsuya Oda · 3 shared papers, 2023–2026 · strength 0.54
- Paper Stromal FAP-targeted 18F-FAPI-74 PET/CT in pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2026.07.004↗
- Paper Lectin-based phototherapy targeting cell surface glycans for pancreatic cancer. DOI 10.1002/ijc.34362↗
- Paper Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally … DOI 10.1186/s12885-023-11110-y↗
- Osamu Shimomura · 3 shared papers, 2023–2026 · strength 0.54
- Paper Stromal FAP-targeted 18F-FAPI-74 PET/CT in pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2026.07.004↗
- Paper Lectin-based phototherapy targeting cell surface glycans for pancreatic cancer. DOI 10.1002/ijc.34362↗
- Paper Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally … DOI 10.1186/s12885-023-11110-y↗
- Yoshihiro Miyazaki · 3 shared papers, 2023–2026 · strength 0.54
- Paper Stromal FAP-targeted 18F-FAPI-74 PET/CT in pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2026.07.004↗
- Paper Lectin-based phototherapy targeting cell surface glycans for pancreatic cancer. DOI 10.1002/ijc.34362↗
- Paper Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally … DOI 10.1186/s12885-023-11110-y↗
- Tomoaki Furuta · 2 shared papers, 2023–2026 · strength 0.41
- Yoshimasa Akashi · 2 shared papers, 2023–2026 · strength 0.41
- Hiromitsu Nakahashi · 2 shared papers, 2023–2026 · strength 0.41
- Shuntaro Tsukamoto · 1 shared paper, 2026 · strength 0.25
- Kentaro Hatano · 1 shared paper, 2026 · strength 0.25
- Yukihito Kuroda · 1 shared paper, 2023 · strength 0.16
- Hiroaki Tateno · 1 shared paper, 2023 · strength 0.16
- Wenchao Gu · 1 shared paper, 2022 · strength 0.15
- Huaxiang Xu · 1 shared paper, 2022 · strength 0.15
- Yoshito Tsushima · 1 shared paper, 2022 · strength 0.15
- Masato Endo · 1 shared paper, 2023 · strength 0.13
- Hideyuki Sakurai · 1 shared paper, 2023 · strength 0.13
- Kiichiro Tsuchiya · 1 shared paper, 2023 · strength 0.13
- Haruko Numajiri · 1 shared paper, 2023 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.